期刊文献+

阿司匹林对人结肠癌细胞中肿瘤干细胞标记物CD44表达的影响 被引量:4

The Effect of Aspirin on Expression of Cancer Stem Cell Marker CD44 in Human Colorectal Cancer Cells
下载PDF
导出
摘要 目的:观察阿司匹林对人结肠癌肿瘤干细胞标志物CD44的影响,以探讨其对结肠癌干细胞的作用。方法:Western blot检测不同浓度阿司匹林作用后CD44在人结肠癌细胞株HT-29和SW480中的表达情况。结果:Western blot结果显示肿瘤干细胞标志物CD44在人结肠癌细胞株HT-29和SW480中均有表达,阿司匹林能降低HT-29和SW480中CD44蛋白的表达,并具有良好的量-效关系(P<0.05);两种细胞中CD44蛋白的表达比较差异均无统计学意义(P>0.05)。结论:阿司匹林能降低结肠癌细胞株HT-29和SW480中CD44的表达,并对结肠癌肿瘤干细胞有抑制作用。 Objective:To investigate the effect of Aspirin on the expression of cancer stem cell marker CD44 in human colon cancer.Method:Western blot was used to detect the expression of CD44 in human colon cancer cell line HT-29 and SW480 after different concentrations of Aspirin.Result:Western blot showed that cancer stem cell marker CD44 expression in both HT-29 and SW480 human colon cancer cell lines,Aspirin could reduce the expression of CD44 HT-29 and SW480,it had a good dose-response relationship(P〈0.05).The expression of CD44 protein in two cells showed no significant difference(P〉0.05).Conclusion:Aspirin can reduce the expression of CD44 in colon cancer cell line HT-29 and SW480,inhibit the proliferation of colon cancer stem cells.
出处 《中国医学创新》 CAS 2017年第1期1-4,共4页 Medical Innovation of China
基金 贵州省高层次人才科研条件特助经费资助项目(TZJF-2011-32) 贵州省科学技术基金项目(CK-988) 遵义医学院附属医院院资金项目(F-572)
关键词 阿司匹林 结直肠癌 肿瘤干细胞标志物 CD44 HT-29 SW480 Aspirin Colorectal cancer Cancer stem cell marker CD44 HT-29 SW480
  • 相关文献

参考文献7

二级参考文献65

  • 1Garcia-Albeniz X,Chan AT. Aspirin for the prevention of colorectal cancer [J].Best Pract Rrs Clin Gastroenterol, 2011,25(4-5):461-472. 被引量:1
  • 2Chan AT, Arber N,Burn J,et al. Aspirin in the chemopre- vention of colorectal neoplasia:an overview[J].Cancer Prey Res,2012,5(2):164-178. 被引量:1
  • 3ZHang X,Smith-Warner SA,Chan AT,et al. Aspirin use, body mass index,physical activity,plasma C-peptide,and colon cancer risk in US health professionals [J].Am J Epidemiol, 2011,174(4):459-467. 被引量:1
  • 4Ruder EH,Laiyemo AO,Graubard BI,et al. Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large ,prospective cohort [J].Am J Gastroenterol, 2011,106 (7):1340-1350. 被引量:1
  • 5Burn J,Bishop DT,Chapman PD,et al. A randomized placebo-controlled prevention trial of aspirin and/or resis- tant starch in young people with familial adenomatous polyposis[J].Cancer Prey Res(Phila), 2011,4(5):655-665. 被引量:1
  • 6Murff HJ,Shrubsole MJ,Chen Z,et al. Nonsteroidal anti-inflammatory drug use and risk of adenomatous and hyperplastic polyps [J].Cancer Prey Res (Phila), 2011,4 (11) : 1799-1807. 被引量:1
  • 7Zubiaurre L,Bujanda Femandez de Pierola L. Aspirin in the prevention of eoloreetal eaneer[J].Gastroenterol Hepatol, 2011,34(5):337-345. 被引量:1
  • 8Giovannucci E,Chan AT. Role of vitamin and mineral supplementation and aspirin use in cancer survivors [J].J Clin Oncol, 2010,28(26):4081-4085. 被引量:1
  • 9Bum J,Gerdes AM,Macrae F,et al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer:an analysis from the CAPP2 randomised controlled trial[J].Lancet, 2011,378(9809):2081-2087. 被引量:1
  • 10Benamouzig R,Uzzan B ,Deyra J ,et al. Prevention by daily soluble aspirin of colorectal adenoma recurrence:4-year results of the APACC randomized trial[J].Gut, 2012,61 (2): 255-261. 被引量:1

共引文献18

同被引文献13

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部